Cuatrecasas advised Invivo Capital, Advent Biotechnology and Takeda Ventures on the round of financing in Integra Therapeutics. At closure of the transaction, the spin-off of Universitat...
Integra Therapeutics’ €4.5 Million Financing Round
Egle Therapeutics’ €40 Million Series A Funding Round
McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures. Egle Therapeutics,...